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AbSTrACT
background: The main healthcare funding systems in Brazil, 
the public and the private healthcare systems (PuHS and PrHS, 
respectively), have peculiar characteristics and cover almost all 
patients referred for percutaneous coronary intervention (PCI). 
Our objective was to identify population differences and PCI 
hospital outcomes in patients using both systems. Methods: 
From August 2006 to November 2010, 4,957 consecutive 
patients were submitted to PCI, 2,802 (56.5%) were from the 
PuHS and 2,155 from the PrHS. results: Patients from the 
PuHS were younger, had less education, greater incidence of 
smoking, prior myocardial infarction (MI), single-vessel disease, 
left ventricular dysfunction, and received more direct stenting. 
In the PrHS group, there was more diabetes, dyslipidemia, 
prior coronary bypass graft surgery (CABG) and PCI, prior 
stroke, chronic renal failure, ST-segment elevation and non-
ST segment elevation acute coronary syndromes, restenotic 
lesions, long lesions, primary PCIs, use of glycoprotein IIb/IIIa 
inhibitors and drug-eluting stents. PCI success (96% vs. 96,1%; 
P = 0.87), MI (1.7% vs. 1.8%; P = 0.72), CABG (0.1% vs. 
0.2%; P = 0.85), stroke (0.1% vs. 0.1%; P > 0.99) and death 
(1% vs. 1.2%; P = 0.48) were not different between groups. 
Conclusions: Patients from the PrHS had greater clinical and 
angiographic complexity than those from the PuHS. However, 
these differences did not affect the success of the procedure 
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rESUMO
resultados da Intervenção Coronária Percutânea  
de Pacientes Tratados pelo Sistema Único de  
Saúde e pela Saúde Suplementar
Introdução: Os principais sistemas de custeio da saúde no 
Brasil, o Sistema Único de Saúde (SUS) e a saúde suplementar 
(SS), têm características peculiares e abrangem a quase totali-
dade dos pacientes encaminhados para intervenção coronária 
percutânea (ICP). Buscamos saber as diferenças populacionais 
e os resultados hospitalares da ICP entre os pacientes desses 
dois sistemas. Métodos: No período de agosto de 2006 a 
novembro de 2010, 4.957 pacientes consecutivos foram sub-
metidos a ICP, 2.802 (56,5%) pertencentes ao SUS e 2.155 
à SS. resultados: Pacientes do SUS eram mais jovens, com 
menor grau de escolaridade, maior ocorrência de tabagismo, 
infarto do miocárdio (IM) prévio, lesões em um único vaso, 
disfunção ventricular esquerda, e utilização da técnica de stent 
direto. No grupo SS ocorreram mais diabetes, dislipidemia, 
revascularizações percutânea e cirúrgica prévias, acidente 
vascular cerebral prévio, insuficiência renal crônica, síndromes 
coronárias agudas, com e sem supradesnivelamento do segmento 
ST, lesões reestenóticas, lesões longas, ICPs primárias, e uso 
de inibidores da glicoproteína IIb/IIIa e de stents farmacológi-
cos. Sucesso da ICP (96% vs. 96,1%; P = 0,87), IM (1,7% 
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and the rate of in-hospital major adverse cardiovascular and 
cerebrovascular events.
 
 
 
 
 
 
 
DESCrIPTOrS: Angioplasty. Stents. Unified Health System. 
Supplemental health.
Percutaneous coronary intervention
The PCIs were performed almost entirely through 
the femoral access route; radial or brachial approaches 
were used in a few cases. The choice of material and 
technique during the procedure were at the surgeon’s 
discretion. Unfractionated heparin was used at the start of 
the procedure at a dose of 70 U/kg to 100 U/kg, except 
in patients who were already using low molecular-weight 
heparin during the 12 hours prior to the surgery. In these 
cases, an additional dose of 0.3 mg/kg of enoxaparin 
was administered intravenously during the – eight to 12 
hours prior to the surgery. All patients received combined 
antiplatelet therapy with acetylsalicylic acid (100-200 mg/
day) and clopidogrel (loading dose of 300-600 mg and 
maintenance dose of 75 mg/day).
Angiographic analysis and definitions
Analyses were performed using at least two ortho-
gonal projections by experienced surgeons using quan-
titative digital angiography. This study used the same 
angiographic criteria as the National Cardiovascular 
Intervention Centre (Central Nacional de Intervenções 
Cardiovasculares – CENIC) of the Brazilian Society of 
Interventional Cardiology.3 Long lesions were defined 
as those with lengths > 20 mm. The Thrombolysis in 
Myocardial Infarction (TIMI) score was used to classify 
the pre- and post-procedural coronary flow.4 Procedural 
success was defined as the achievement of angiographic 
success (residual stenosis < 30% with TIMI flow 3) 
and the absence of major adverse cardiovascular, and 
cerebrovascular events, i.e., death from any cause, 
myocardial infarction (MI), stroke, and emergency CABG 
surgery.5 Post-PCI myocardial infarction was defined 
by the presence of new ischaemic electrocardiogram 
alterations, > three-fold upregulation of laboratory 
markers compared to the upper normal value, and/or 
angiographic evidence of target vessel occlusion. 
Emergency CABG surgery was considered when it was 
performed immediately after the PCI.
Statistical Analysis
The data stored in an Oracle database were plotted 
in Excel spreadsheets and analyzed with SPSS software, 
C oronary artery disease is a major cause of morbi dity and mortality in Brazil, and is responsible for high costs in both the Unified Health System (Sistema 
Único de Saúde – SUS), which relies on public funding, 
as well as the supplemental health (SH) system, which 
utilizes private funding. In 2010, 55,754 percutaneous 
coronary interventions (PCIs) were performed in SUS 
patients, which cost over R$ 85 million.1
These two healthcare systems have specific char-
acteristics and cover almost all patients referred for 
PCI. The public health system, SUS, in spite of its 
concept of universality, does not make drug-eluting 
stents avai lable, the device of choice in PCIs performed 
in developed countries. SUS also limits the use of 
stents to, at most, two devices per procedure, which 
makes the percuta neous treatment of coronary artery 
disease more complex, generating staged interventions 
or referrals for coronary artery bypass graft (CABG) 
surgery, which are associated with higher costs.2 The 
SH system does not have these limitations; however, 
there is an increasing demand from health plan agen-
cies for medical justifications for the interventions and 
for the materials needed.
The aim of this study was to assess the impact of 
these differences on the in-hospital PCI outcomes in an 
institution that provides care to patients who belong to 
either of the two healthcare systems available in Brazil. 
MethodS
Patients
From August 2006 to November 2010, 4,957 con-
secutive patients underwent PCI at the Interventional 
Cardiology Department at the Hospital Bandeirantes 
(São Paulo, SP). Among these, 2,802 (56.5%) were SUS 
patients and 2,155 were SH patients, constituting the two 
groups compared in this study. Clinical, angiographic 
and procedural characteristics were compared, as well 
as the success rates and incidence of adverse events 
until hospital discharge.
The data were prospectively collected and stored 
in a computer database for future analysis.
vs. 1,8%; P = 0,72), cirurgia de revascularização (0,1% vs. 
0,2%; P = 0,85), acidente vascular cerebral (0,1% vs. 0,1%; 
P > 0,99) e óbito (1% vs. 1,2%; P = 0,48) hospitalares não 
diferiram entre os grupos. Conclusões: Os pacientes da SS 
apresentaram-se com maior complexidade clínica e angiográfica 
que os do SUS. No entanto, essas diferenças não alteraram 
o sucesso do procedimento e os eventos cardiovasculares e 
cerebrovasculares adversos maiores hospitalares.
 
DESCrITOrES: Angioplastia. Stents. Sistema Único de Saúde. 
Saúde suplementar.
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version 15.0. Continuous variables were expressed as 
means and standard deviations, and categorical varia-
bles were expressed as absolute numbers and percen-
tages. Associations between continuous variables were 
evaluated by Student’s t-test or the Mann-Whitney test. 
Associations between categorical variables were eva-
luated using the chi-squared or Fisher’s exact test, using 
2×2 tables. For larger tables, the chi-squared test or the 
likelihood ratio (G) was applied. A significance level 
of P < 0.05 was used for all analyses.
ReSultS
The SUS group was three years younger (60.6 ± 
11.3 years vs. 64 ± 12.4 years; P < 0.01), had a lower 
degree of education, higher incidence of smoking (26.8% 
vs. 18.3%; P < 0.01) and previous incidence of MI 
(19.6% vs. 16%; P < 0.01). The HS group had more 
incidence of (27.5% vs. 31.6%; P < 0.01), dyslipidemia 
(28% vs. 40.7%; P < 0.01), CABG (6.7% vs. 17.1%; 
P <  0.01), previous PCI (14.7% vs. 19.9%; P <  0.01), 
previous stroke (2% vs. 3.2%; P = 0.01), chronic renal 
failure (2.3% vs. 3.2%; P = 0.04), and acute coronary 
syndromes, with and without ST-segment elevation, as 
the initial clinical presentation (Table 1).
Regarding angiographic characteristics (Table 2), 
the SUS group showed a higher frequency of patients 
with single-vessel disease (57.6% vs. 50.3%) and left 
ventricular dysfunction (23.9% vs. 17%; P < 0.01). The 
SH group had more patients with restenosis (2.4% vs. 
4.9%; P < 0.01) and longer lesions (10.9% vs. 16.3%; 
Table 1 
Demographic and clinical characteristics
Characteristic
SUS
(n = 2,802)
SH
(n = 2,155) P-value
Age, years 60.6 ± 11.3 64 ± 12.4 < 0.01
Male gender 1,922 (68.6) 1,468 (68.1) 0.73
Degree of schooling < 0.01
Illiterate 25 (1) 18 (1)
1st to 4th grades 893 (35.2) 497 (26,7)
5th to 8th grades 1,039 (41) 453 (24.3)
High School 534 (21.1) 546 (29,3)
College or university 45 (1.8) 344 (18.5)
Master’s or Doctoral degree 0 (0) 3 (0.2)
Diabetes, n (%) 771 (27.5) 681 (31.6) < 0.01
Arterial hypertension 2,095 (74.8) 1,590 (73.8) 0.43
Dyslipidemia, n (%) 784 (28) 878 (40.7) < 0.01
Smoking, n (%) 750 (26.8) 395 (18.3) < 0.01
Previous myocardial infarction, n (%) 549 (19.6) 344 (16) < 0.01
Previous CABG surgery, n (%) 188 (6.7) 368 (17.1) < 0.01
Previous percutaneous coronary intervention, n (%) 412 (14.7) 428 (19.9) < 0.01
Chronic renal failure, n (%) 64 (2.3) 68 (3.2) 0.04
Previous stroke, n (%) 56 (2) 68 (3.2) 0.01
Quadro clínico por Clinical picture < 0.01
Asymptomatic 922 (32.9) 485 (22.5)
Ischemic equivalent 124 (4.5) 158 (7.4)
Unstable angina 727 (18.9) 592 (27.5)
NSTE-ACS 320 (11.4) 456 (21.2)
STEMI 340 (12.1) 330 (15.3)
Late-phase myocardial infarction 370 (13.2) 135 (6.3)
SUS, Unified Health System; SH, supplemental health; CABG, coronary artery bypass graft; NSTE-ACS, non-ST-segment elevation acute 
coronary syndrome; STEMI, ST-segment elevation myocardial infarction.
Ganassin et al. 
PCI Outcomes in Patients Treated by Public and Private Healthcare Systems
Rev Bras Cardiol Invasiva. 
2012;20(4):386-91
389
Table 2 
Angiographic characteristics
Characteristic
SUS 
2,802 patients/ 3,632 
SH  
2,155 patients/ 
2,755 lesions P-value
Coronary disease extension, n (%) < 0.01
Single-vessel 1,131 (57.6) 734 (50.3)
Two-vessel 595 (30.3) 435 (29.8)
Three-vessel 215 (11) 254 (17.4)
Left ventricular dysfunction, n (%) 413 (23.9) 232 (17) < 0.01
Restenotic lesions, n (%) 87 (2.4) 136 (4.9) < 0.01
Calcified lesions, n (%) 170 (4.7) 158 (5.7) 0.08
Long lesions, n (%) 395 (10.9) 452 (16.3) < 0.01
Lesions with thrombi, n (%) 69 (1.9) 110 (2.9) 0.10
Bifurcations, n (%) 515 (14.2) 358 (12.9) 0.34
TIMI pre, n (%) 0.32
0/1 225 (6.2) 150 (5.4)
2/3 3,407 (93.8) 2,625 (94.6)
Treated vessel 0.37
ADA 1,416 (38.9) 1,071 (38.6)
Cx 766 (21.1) 527 (19)
RCA 1,198 (3.3) 899 (32,4)
LMCA 37 (1) 25 (0.9)
SUS, Unified Health System; SH, supplemental health; TIMI, Thrombolysis in Myocardial Infarction; ADA, anterior descending artery; 
Cx, circumflex artery; RCA, right coronary artery; LMCA, left main coronary artery.
Table 3 
Characteristics of the procedures
Characteristic
SUS
2,802 patients/ 
3,632 
SH  
2,155 patients/ 
2,755 lesions P-value
PCI type, n (%) < 0.01
Elective 1,405 (50.1) 1,133 (52.6)
Urgency 101 (3.6) 164 (7.6)
Ad hoc 959 (34.2) 551 (25.6)
Primary 220 (7.9) 273 (12.7)
Rescue 117 (4.2) 34 (1.5)
PCI with stenting, n (%) 3,385 (93.1) 2,608 (94) 0.79
PCI with DES, n (%) 0 480 (18.4) < 0.01
IIb/IIIa Use oflycoprotein inhibitors, n (%) 132 (4.7) 228 (10.6) < 0.01
Direct stenting technique, n (%) 1,597 (47.2) 972 (37.3) < 0.01
Stent diameter, mm 2.96 ± 0.48 2.96 ± 0.49 0.78
Stent length, mm 17.8 ± 6.7 19.2 ± 7.2 < 0.01
Degree of stenosis, %
Pre 84.7 ± 12.5 83.9 ± 12.2 0.76
Post 1 ± 7.8 1,4 ± 8 0.07
Procedural success 2,689 (96) 2,070 (96.1) 0.87
SUS, Unified Health System; SH, supplemental health; PCI, percutaneous coronary intervention; DES, drug-eluting stent
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The greater number of patients in the SH group 
with previous revascularization, either surgical or per-
cutaneous, may be related to the difficulty of access to 
health services of high complexity among SUS patients. 
This difficulty can also explain the differences from the 
AMI treatment, in which there is a greater number of 
SH patients treated in the acute phase, resulting in a 
higher frequency of primary PCIs, and the use of gly-
coprotein IIb/IIIa. Conversely, the SUS group showed 
a higher number of PCIs performed at a later phase 
of AMI. In a recently published comparative analysis 
between SUS and SH patients with primary PCI data 
in the present hospital, there was a longer delay in the 
transference of SUS patients from the center of origin 
to the referral hospital.9 
The greater clinical complexity of the SH group, 
which contained a higher number of diabetic patients, 
patients with previous revascularizations, and patients 
with chronic renal failure, reflected a greater angiographic 
complexity. Multivessel patients with longer and restenotic 
lesions were more frequent in this group. Patients with 
such clinical and angiographic complexities constitute 
the scenario where the use of DES has demonstrated its 
most significant benefits in terms of reducing restenosis 
and new interventions in relation to BMS.10-13 In this 
hospital, the use of DES in approximately 20% of the 
patients (according to the Brazilian mean in the CENIC 
registry)3 mainly includes the most complex cases. The 
availability of DES only in the SH justifies the difference 
in clinical and angiographic complexity between the 
groups. The SUS rule that establishes the use of only 
two stents per procedure, which are necessarily BMS, 
limits the optimal application of PCI in patients with 
multivessel disease and diabetes. Consequently, this directs 
them to staged procedures or surgical revascularization, 
which may result in higher costs.
The lower angiographic complexity in the SUS group 
allowed the use of shorter stents and direct stenting 
techniques without pre-dilatation in almost half of the 
lesions treated. As the direct stenting technique has a 
high rate of failure in calcified, long lesions and in 
the presence of tortuosities, it has been used in less 
complex lesions.14
P < 0.01). There were no differences in the pre-procedure 
TIMI flow, the type of vessel treated, and lesions with 
thrombi or bifurcations.
Regarding procedural characteristics (Table 3), there 
was a predominance of the use of the direct stenting 
technique (47.2% vs. 37.3%; P < 0.01). In the SH 
group, there was a higher occurrence of primary PCIs 
and the use of glycoprotein IIb/IIIa inhibitors (4.7% vs. 
10.6%; P  <  0.01). The use of DES was unique to the 
SH group, representing 18.4% of the total number of 
stents used. The mean length of the stents was higher 
in the SH group (17.8 ± 6.7 mm vs. 19.2 + 7.2 mm; 
P < 0.01), with no differences regarding the diameter and 
quantification of obstructions pre- and post-procedure 
in the two groups.
The rates of PCI success (96% vs. 96.1%; P = 
0.87), in-hospital MI (1.7% vs. 1.8%; P = 0.72), CABG 
(0.1% vs. 0.2%; P = 0.85), stroke (0.1% vs. 0.1%; 
P > 0.99), and death (1% vs. 1.2%; P = 0.48) did not 
differ between the two groups (Table 4).
diScuSSion
In the present study, the differences between the 
two health systems, especially regarding universal and 
free access to SUS services, the limitation in the number 
of stents used per procedure, and the non-availability 
of DES resulted in differences in the composition of the 
two groups with regard to their demographic, clinical, 
angiographic, and procedural characteristics.
The SH group was three years older, a fact that 
may reflect better cardiovascular prevention and primary 
care in this population. Women, as well as diabetics, 
numbered approximately one-third of patients in both 
groups, figures that have been repeated in several 
registries.3,6 In this study, smoking showed a similar 
incidence to that found in a Brazilian epidemiologi-
cal study, which also showed a higher incidence in a 
population with lower levels of education.7 The rate of 
dyslipidemia was greater in SH group patients; however, 
the values were consistent with the average values 
found in the literature.8
Table 4 
In-hospital clinical outcomes
Characteristic
SUS 
(n = 2,802)
SH  
(n = 2,155) P-value
Mortality, n (%) 28 (1) 26 (1.2) 0.48
Myocardial infarction, n (%) 47 (1.7) 39 (1.8) 0.72
Emergency CABG surgery, n (%) 3 (0.1) 4 (0.2) 0.85
Stroke, n (%) 3 (0.1) 3 (0.1) > 0.99
SUS, Unified Health System; SH, supplemental health; CABG, coronary artery bypass graft.
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Procedural success, which was high in both groups, 
and clinical outcomes (death, stroke, MI, and urgent 
revascularization) were similar despite the distinct 
profiles. The possibility of using new technologies, 
including drug-eluting stents in SH, had a positive in-
fluence, providing in-hospital results similar to those of 
the group with less complex clinical and angiographic 
characteristics (SUS). The incorporation of DES by SUS 
would significantly broaden the benefits of PCI, espe-
cially for more complex patients for whom its clinical 
benefits are unquestionable.
Study limitations
There are certain limitations of the present study: 
the retrospective analysis of data from two cohorts 
with non-adjusted clinical variables, the fact that it 
was conducted in a single center, and the absence of 
late follow-up.
concluSionS
Patients in the SH group showed greater clinical 
and angiographic complexity than patients in the SUS 
group. However, these differences did not have an effect 
on procedural success and in-hospital major adverse 
cardiovascular and cerebrovascular events.
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